Sign in to continue:

Saturday, February 14th, 2026

PEOPLElogy Berhad’s RM26.25 Million IPO: Pioneering Digital Talent Development Across Southeast Asia

IPO Details

Purpose of IPO: PEOPLElogy aims to raise RM26.25 million through the issuance of 105 million new shares at RM0.25 each. The proceeds are allocated as follows:

  • Expansion into East Malaysia and Southeast Asia (Kota Kinabalu, Kuching, Indonesia, Philippines, and a regional office in Singapore).

  • Establishment of a computer simulation lab to enhance cybersecurity, big data, and AI programs.

  • Research and development, working capital, and listing expenses.

Oversubscription: The IPO was oversubscribed by 1.24 times, indicating strong investor interest.

IPO Placement and Outstanding Shares

  • Shares Offered: 105 million new shares at RM0.25 per share.

  • Outstanding Shares Post-IPO: 411.72 million shares.

  • Market Capitalization: Approximately RM102.93 million based on the IPO price.

Given the oversubscription and strategic expansion plans, the IPO is likely to perform well on its first day of listing.


Institutional and Anchor Investors

  • Institutional Investors: Specific names of institutional or anchor investors have not been disclosed.


Investment Banker, Underwriter, and Sponsors

  • Principal Adviser, Sponsor, Underwriter, and Placement Agent: Kenanga Investment Bank Bhd.

The involvement of a reputable financial institution like Kenanga Investment Bank Bhd adds credibility and is likely to positively influence the IPO’s performance.


Company Overview

Business Model and Industry: PEOPLElogy is an integrated people development solutions provider, offering talent consultancy, ICT training, digital skills certification, event organization, and digital learning platforms.

Financial Health:

  • Revenue (2023): RM24.73 million

  • Net Profit (2023): RM5.8 million

  • Net Profit (Q1 2024): RM42,000

Market Position: PEOPLElogy operates across three segments: Development, Digital, and Discovery, targeting B2B, B2G, and B2C markets in Malaysia and Southeast Asia.

Management Team:

  • Managing Director: Allen Lee

  • Chief Executive Officer: Cally Yau

  • Chief Operating Officer: Joey Lee


Market and Economic Factors

Sector Trends: Malaysia’s talent development market reached RM16.0 billion in 2023, with a CAGR of 21.7% since 2021. Digital training programs have shown even faster growth at 24.0% CAGR. The market is projected to reach RM34.7 billion by 2027.

Timing of IPO: The IPO is scheduled for listing on May 20, 2025.

Economic Environment: The increasing need for a digitally skilled workforce in Malaysia supports the demand for PEOPLElogy’s services.

Risk Factors:

  • Dependence on key clients (e.g., Yayasan Peneraju contributed 45% to revenue in 2023)

  • Economic downturns affecting training budgets

  • Competition from other training providers

Growth Strategy: PEOPLElogy plans to expand its presence in East Malaysia and Southeast Asia, establish new training centers, and invest in R&D for digital platforms.

Ownership Structure: Post-IPO, the company’s enlarged issued share capital will be 411.72 million shares.

 


Research and Expert Opinions

Mercury Securities: Recommends subscribing to the IPO with a fair value of RM0.28, based on a 15.4x FY2026E EPS, translating to a 12% potential upside.


IPO Allotment Result

Oversubscription: The IPO was oversubscribed by 1.24 times, indicating strong investor interest.


Investment Recommendation and Price Estimate

Given the company’s strategic expansion plans, strong market demand for digital training, and positive analyst recommendations, the IPO appears to be a promising investment. The stock is expected to trade slightly above its IPO price of RM0.25 on the first day of listing.


Prospectus Download

The IPO prospectus can be downloaded from Bursa Malaysia’s website

Thank you

Maybank (1155 KL), Public Bank (1295 KL), CIMB Group (1023 KL), Hong Leong Bank (5819 KL), RHB Bank (1066 KL), AMMB Holdings (1015 KL), Alliance Bank Malaysia (2488 KL), BIMB Holdings (5258 KL)

Maybank (1155 KL), Public Bank (1295 KL), CIMB Group (1023 KL), Hong Leong Bank (5819 KL), RHB Bank (1066 KL), AMMB Holdings (1015 KL), Alliance Bank Malaysia (2488 KL), BIMB Holdings (5258 KL) 🏦...

Sichuan Biokin Pharmaceutical (688506) Hong Kong IPO: Innovative Oncology Pipeline, Global Strategy & Key Risk Factors Explained

Baili Pharmaceutical IPO Analysis: Growth, Strategy & Outlook for Investors Company Name: Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical IPO: In-Depth Analysis, Growth Prospects, and Investor Outlook Baili Pharmaceutical’s...

Nam Cheong Poised for Growth: Undervalued Offshore Vessel Provider Set to Benefit from Sarawak Oil & Gas Demand 1

Broker Name: DBS Date of Report: (Date not provided in the document) Excerpt from DBS report. Report Summary: Nam Cheong, a leading offshore support vessel provider, is expected to benefit from higher OSV demand...

   Ad